Citadel Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.28M Buy
+27,900
New +$1.35M ﹤0.01% 7832
2026
Q1
– Sell
-5,500
Closed -$232K – 14309
2025
Q4
$232K Buy
+5,500
New +$222K ﹤0.01% 10712
2025
Q2
– Sell
-2,300
Closed -$68.2K – 15259
2025
Q1
$68.2K Buy
2,300
+1,700
+283% +$64.8K ﹤0.01% 11951
2024
Q4
$23.8K Sell
600
-100
-14% -$3.79K ﹤0.01% 13061
2024
Q3
$23.8K Sell
700
-2,700
-79% -$76K ﹤0.01% 12641
2024
Q2
$73.7K Sell
3,400
-27,300
-89% -$574K ﹤0.01% 11311
2024
Q1
$680K Buy
30,700
+400
+1% +$9.8K ﹤0.01% 7725
2023
Q4
$834K Buy
30,300
+18,700
+161% +$451K ﹤0.01% 7040
2023
Q3
$259K Sell
11,600
-9,300
-44% -$239K ﹤0.01% 9433
2023
Q2
$532K Buy
20,900
+2,600
+14% +$63K ﹤0.01% 7803
2023
Q1
$408K Buy
18,300
+10,100
+123% +$244K ﹤0.01% 8731
2022
Q4
$195K Buy
+8,200
New +$191K ﹤0.01% 10185
2022
Q3
– Sell
-42,400
Closed -$844K – 13670
2022
Q2
$844K Buy
42,400
+18,500
+77% +$374K ﹤0.01% 7427
2022
Q1
$659K Buy
23,900
+18,600
+351% +$532K ﹤0.01% 8724
2021
Q4
$218K Sell
5,300
-700
-12% -$30.9K ﹤0.01% 11669
2021
Q3
$279K Sell
6,000
-7,600
-56% -$332K ﹤0.01% 11210
2021
Q2
$544K Buy
13,600
+2,700
+25% +$115K ﹤0.01% 9887
2021
Q1
$586K Buy
+10,900
New +$628K ﹤0.01% 9337
2019
Q3
– Sell
-13,300
Closed -$379K – 9788
2019
Q2
$379K Sell
13,300
-700
-5% -$17.5K ﹤0.01% 7238
2019
Q1
$350K Buy
+14,000
New +$267K ﹤0.01% 7386
2017
Q3
– Sell
-17,600
Closed -$147K – 8092
2017
Q2
$147K Buy
17,600
+3,600
+26% +$29.4K ﹤0.01% 6758
2017
Q1
$129K Sell
14,000
-3,700
-21% -$30.3K ﹤0.01% 6759
2016
Q4
$137K Buy
+17,700
New +$132K ﹤0.01% 6551
2016
Q3
– Sell
-10,000
Closed -$50K – 7821
2016
Q2
$50K Sell
10,000
-9,200
-48% -$49.3K ﹤0.01% 6408
2016
Q1
$104K Buy
+19,200
New +$114K ﹤0.01% 6009

Other funds holding VCYT

Citadel Advisors's VCYT Position: Q3 2026 in Review

Citadel Advisors opened a new position in Veracyte (VCYT) in Q3 2026: 93,410 shares worth $4.3M. The stake represents ﹤0.01% of the portfolio and ranks #5130 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in VCYT as recently as Q1 2026.

Citadel Advisors first reported a position in VCYT in Q4 2015 and has held it in 35 quarters since. The position peaked at $25.5M in Q1 2023. 381 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Citadel Advisors held 93,410 shares of Veracyte worth $4.3M as of Q3 2026.
  • Veracyte was a new Citadel Advisors position in Q3 2026.
  • Veracyte made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #5130 holding.
  • Citadel Advisors first reported a position in Veracyte in Q4 2015 and has held it in 35 quarters since.
  • Citadel Advisors's Veracyte position peaked at $25.5M in Q1 2023.
  • 381 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.